Brainlab said it won FDA clearance for a mobile version of its TraumaCad surgical planning software for hip replacement procedures.
The product, TraumaCad Mobile, will be marketed by Brainlab’s Voyant Health unit. The application is compatible with Mac and PC web browsers plus iOS mobile devices.
Toshiba Medical Systems Corp. came one step closer the $273 million acquisition of Vital Images Inc. (NSDQ:VTAL) with the announcement that the initial tender offer period had expired.
A total of 11.9 million shares were tendered by expiration time, representing about 72 percent of Vital Images’ outstanding common stock on a fully diluted basis.
MassDevice Network
@MassDevice
LinkedIn
YouTube